|Awarded On||August 20, 2014|
|Title||Educating Hispanic adolescents and their families on cervical cancer prevention and HPV vaccination in community and clinic settings|
|Award Mechanism||Competitive Continuation/Expansion - Health Behavior Change Through Public Education|
|Institution/Organization||The University of Texas Health Science Center at San Antonio|
|Principal Investigator/Program Director||Daisy Morales-Campos|
|Cancer Sites||Cervix Uteri|
Need: Women in the Lower Rio Grande Valley (LRGV) experience higher incidence and mortality from cervical cancer compared to the state and nation. Prevention of cervical cancer is possible through use of two vaccines (a bivalent and a quadrivalent vaccine), which protect against two strains of HPV (16, 18) that cause 70% of cervical cancer cases. The vaccine is recommended for women/men (aged 18-26) and girls/boys (aged 11-17).
A smaller proportion of Hispanic girls in Texas aged 13-17 compared to Hispanic girls nationwide initiate the vaccine series (57% vs. 63%), and fewer receive all three doses (31% vs 36%). This proportion falls short of the Healthy People 2020 target of 80% of girls ag...